The contribution of TNFα to synaptic plasticity and nervous system function

Advances in Experimental Medicine and Biology

Volumn 691, Issue , 2011, Pages 541-557

  Stellwagen, David ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; ANTIDEPRESSANT AGENT; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; POLO LIKE KINASE 2; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR 1;

AMYOTROPHIC LATERAL SCLEROSIS; BIPOLAR DEPRESSION; CONFERENCE PAPER; CYTOKINE RELEASE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NERVOUS SYSTEM FUNCTION; NEUROPATHIC PAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THERAPY RESISTANCE; ANIMAL; ARTICLE; GLIA; METABOLISM; MOUSE; NERVOUS SYSTEM; PATHOLOGY; PHYSIOLOGY; SYNAPSE; VISUAL CORTEX;

ANIMALS; HUMANS; MICE; NERVOUS SYSTEM; NEUROGLIA; NEURONAL PLASTICITY; RECEPTORS, AMPA; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SYNAPSES; TUMOR NECROSIS FACTOR-ALPHA; VISUAL CORTEX;

EID: 79954439709     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6612-4_57     Document Type: Conference Paper

References (97)

1. Vitkovic L, Maeda S, Sternberg E (2001) Anti-inflammatory cytokines: Expression and action in the brain. Neuroimmunomodulation 9:295-312
2. Pan W et al (1997) Tumor necrosis factor-alpha: A neuromodulator in the CNS. Neurosci Biobehav Rev 21:603-613
3. Perry SW, Dewhurst S, Bellizzi MJ, Gelbard HA (2002) Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk? J Neurovirol 8:611-624
4. Vitkovic L et al (2000) Cytokine signals propagate through the brain. Mol Psychiatry 5: 604-615
5. Beattie EC et al (2002) Control of synaptic strength by glial TNFalpha. Science 295: 2282-2285
6. Malinow R,Malenka RC (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103-126
7. Turrigiano G (2007) Homeostatic signaling: The positive side of negative feedback. Curr Opin Neurobiol 17:318-324
8. Davis GW (2006) Homeostatic control of neural activity: From phenomenology to molecular design. Annu Rev Neurosci 29:307-323
9. Abbott LF, Nelson SB (2000) Synaptic plasticity: Taming the beast. Nat Neurosci 3(Suppl):1178-1183
10. Turrigiano GG, Nelson SB (2004) Homeostatic plasticity in the developing nervous system. Nat Rev Neurosci 5:97-107
11. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB (1998) Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391:892-896
12. Burrone J, Murthy VN (2003) Synaptic gain control and homeostasis. Curr Opin Neurobiol 13:560-567
13. Burrone J, O'Byrne M, Murthy VN (2002) Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons. Nature 420:414-418
14. Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054-1059
15. Shepherd JD et al (2006) Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 52:475-484
16. Rial Verde EM, Lee-Osbourne J, Worley PF, Malinow R, Cline HT (2006) Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron 52:461-474
17. Chen N, Napoli JL (2008) All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. FASEB J 22:236-245
18. Aoto J, Nam CI, Poon MM, Ting P, Chen L (2008) synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity. Neuron 60:308-320
19. Seeburg DP, Pak D, Sheng M (2005) Polo-like kinases in the nervous system. Oncogene 24:292-298
20. Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25: 3219-3228
21. Kwak S, Weiss JH (2006) Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol 16:281-287
22. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS (1996) Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 16:1982-1989
23. Ogoshi F et al (2005) Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole- propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp Neurol 193:384-393
24. Washburn MS, Numberger M, Zhang S, Dingledine R (1997) Differential dependence on GluR2 expression of three characteristic features of AMPA receptors. J Neurosci 17: 9393-9406
25. Mainen ZF, Jia Z, Roder J, Malinow R (1998) Use-dependent AMPA receptor block in mice lacking GluR2 suggests postsynaptic site for LTP expression. Nat Neurosci 1:579-586
26. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61
27. Isaac JT, Ashby M, McBain CJ (2007) The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 54:859-871
28. Lai C et al (2006) Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J Neurosci 26:11798-11806
29. Spalloni A et al (2004) Cu/Zn-superoxide dismutase (GLY93->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol Dis 15:340-350
30. Hartmann B et al (2004) The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain. Neuron 44:637-650
31. Bellone C, Luscher C (2006) Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci 9:636-641
32. Plant K et al (2006) Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci 9:602-604
33. Bagal AA, Kao JP, Tang CM, Thompson SM (2005) Long-term potentiation of exogenous glutamate responses at single dendritic spines. Proc Natl Acad Sci USA 102:14434-14439
34. Ju W et al (2004) Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors. Nat Neurosci 7:244-253
35. Thiagarajan TC, Lindskog M, Tsien RW (2005) Adaptation to synaptic inactivity in hippocampal neurons. Neuron 47:725-737
36. Sutton MA et al (2006) Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell 125:785-799
37. Gainey MA, Hurvitz-Wolff JR, Lambo ME, Turrigiano GG (2009) Synaptic scaling requires the GluR2 subunit of the AMPA receptor. J Neurosci 29:6479-6489
38. Auld DS, Robitaille R (2003) Glial cells and neurotransmission: An inclusive view of synaptic function. Neuron 40:389-400
39. Haydon PG (2001) GLIA: Listening and talking to the synapse. Nat Rev Neurosci 2:185-193
40. Bezzi P, Volterra A (2001) A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 11:387-394
41. Ullian EM, Christopherson KS, Barres BA (2004) Role for glia in synaptogenesis. Glia 47:209-216
42. Christopherson KS et al (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120:421-433
43. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001) Control of synapse number by glia. Science 291:657-661;
44. [Comment In: Science. 2001 Jan 26;291(5504):569-70 UI: 21121053]
45. Bains JS, Oliet SH (2007) Glia: They make your memories stick! Trends Neurosci 30:417-424
46. Kaneko M, Stellwagen D, Malenka RC, Stryker MP (2008) Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron 58:673-680
47. Pittenger C, Duman RS (2008) Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 33:88-109
48. Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201-217
49. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27:24-31
50. Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P (2003) Raised plasma levels of tumor necrosis factor alpha in patients with depression: Normalization during electroconvulsive therapy. J Ect 19:183-188
51. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170:429-433
52. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379
53. O'Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. J Affect Disord 90:263-267
54. Pae CU, Lee KU, Han H, Serretti A, Jun TY (2004) Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population. Psychiatry Res 125:65-68
55. Jun TY et al (2003) Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet 13:179-181
56. Reynolds JL, Ignatowski TA, Sud R, Spengler RN (2005) An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience 133:519-531
57. Bluthe RM et al (2000) Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: A study with interleukin-1 type I receptordeficient mice. Eur J Neurosci 12:4447-4456
58. Yirmiya R et al (2000) Illness, cytokines, and depression. Ann N Y Acad Sci 917:478-487
59. Dantzer R (2004) Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol 500:399-411
60. Reichenberg A et al (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445-452
61. Meyers CA (1999) Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol 461:75-81
62. Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ (2002) Treatment of cytokineinduced depression. Brain Behav Immun 16:575-580
63. Simen BB, Duman CH, Simen AA, Duman RS (2006) TNFalpha signaling in depression and anxiety: Behavioral consequences of individual receptor targeting. Biol Psychiatry 59: 775-785
64. Sahay A, Hen R (2007) Adult hippocampal neurogenesis in depression. Nat Neurosci 10:1110-1115
65. Iosif RE et al (2006) Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 26:9703-9712
66. Obuchowicz E et al (2006) Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol 9:27-35
67. Airan RD et al (2007) High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317:819-823
68. Kim J, Tsien RW (2008) Synapse-specific adaptations to inactivity in hippocampal circuits achieve homeostatic gain control while dampening network reverberation. Neuron 58: 925-937
69. Huh GS et al (2000) Functional requirement for class I MHC in CNS development and plasticity. Science 290:2155-2159
70. Stevens B et al (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164-1178
71. Shohami E, Novikov M, Bass R, Yamin A, Gallily R (1994) Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 14: 615-619
72. Combs CK, Karlo JC, Kao SC, Landreth GE (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188
73. Rieckmann P et al (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37:82-88
74. Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T (1995) TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 154:944-953
75. Powers JM, Liu Y, Moser AB, Moser HW (1992) The inflammatory myelinopathy of adrenoleukodystrophy: Cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 51:630-643
76. Curfs JH et al (1993) Tumour necrosis factor-alpha and macrophages in Plasmodium bergheiinduced cerebral malaria. Parasitology 107:125-134
77. New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA (1998) HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem 273:17852-17858
78. Bezzi P et al (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702-710
79. Boillee S, Vande Velde C, Cleveland DW (2006) ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59
80. Rao SD, Weiss JH (2004) Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci 27:17-23
81. Bendotti C, Carri MT (2004) Lessons from models of SOD1-linked familial ALS. Trends Mol Med 10:393-400
82. Nagai M et al (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10:615-622
83. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10:608-614
84. Clement AM et al (2003)Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-117
85. Mhatre M, Floyd RA, Hensley K (2004) Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets. J Alzheimers Dis 6:147-157
86. Kiaei M et al (2006) Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 26:2467-2473
87. Weydt P, Moller T (2005) Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport 16:527-531
88. Yoshihara T et al (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80:158-167
89. Weydt P, Yuen EC, Ransom BR, Moller T (2004) Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 48:179-182
90. Sedel F, Bechade C, Vyas S, Triller A (2004) Macrophage-derived tumor necrosis factor alpha, an early developmental signal for motoneuron death. J Neurosci 24:2236-2246
91. Elliott JL (2001) Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 95:172-178
92. Van Damme P, Braeken D, Callewaert G, Robberecht W, Van Den Bosch L (2005) GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 64:605-612
93. Corona JC, Tapia R (2007) Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo. Neuropharmacology 52:1219-1228
94. Van Damme P etal (2007) Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci USA 104(37):14825-14830
95. Yin HZ, Sensi SL, Ogoshi F, Weiss JH (2002) Blockade of Ca2+-permeable AMPA/kainate channels decreases oxygen-glucose deprivation-induced Zn2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J Neurosci 22:1273-1279
96. Bernardino L et al (2005) Modulator effects of interleukin-1beta and tumor necrosis factoralpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J Neurosci 25:6734-6744
97. Lebrun-Julien F et al (2009) Excitotoxic death of retinal neurons in vivo occurs via a noncell- autonomous mechanism. J Neurosci 29:5536-5545